The cancer treatment technology developer's series C was led by Philips Health Technology Ventures and backed by Debiopharm and Cerner.
US-based, oncology-focused health technology developer Carevive Systems has completed an $18m series C round led by Philips Health Technology Ventures, an investment vehicle for medical device and electronics group Philips. The round included pharmaceutical company Debiopharm’s Innovation Fund, health IT equipment producer Cerner, Qure Ventures, HLM Venture Partners, LRVHealth, OurCrowd’s digital health fund and Carevive…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
